600085.SH
Beijing Tong RenTang Co., Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 24.69
−0.84%Year over year
Reported trailing growth
- Revenue
- -10.5%
- EBITDA
- —
- EBIT
- -35.4%
- EPS
- -29.6%
- Free cash flow
- +82.9%
- Operating cash flow
- +51.9%
Forward estimates
Based on analyst estimates
- Revenue
- -15.3%
- EBITDA
- +11.1%
- EPS
- +24.6%
Three-year CAGR
- Revenue
- +3.9%
- EBITDA
- -7.3%
- EBIT
- -9.3%
- Net income
- -5.9%
- EPS
- -5.9%
- Free cash flow
- -5.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026